LCN2 and focal segmental glomerulosclerosis: Zhang et al. confirmed that urinary NGAL is a good biomarker of tubulointerstitial lesions in FSGS patients and could be useful in diagnosing FSGS, detecting acute tubulointerstitial lesions, and predicting treatment response [47].